QuestCap covered all starting from Testing to TreatmentQuestCap can generate lot of revenue from these cubes offering covid-19 testing then vaccination. Once you have all that money, you can get into all kind of business. Doug Sommerville know the need in medical related service, he knows people in this industry, he knows in and out of medical related business. He worked at Teva Canada, which is known as the leading provider of generic medicines in the world. Teva Canada boasted sales in excess of $1.3 billion. Sommerville oversaw all aspects of its commercial, distribution, demand planning, and customer operations until his retirement in 2018.
Prior to that, he was global vice president, infusion systems with Baxter Healthcare International, which stands among the largest medical, pharmaceutical, and technology companies in the world. He was responsible for Baxter’s infusion-pumping devices and intravenous administration sets worldwide, as well as the company’s pain management and ambulatory infusion devices.
https://www.wealthprofessional.ca/news/people-moves/questcap-names-new-ceo-executive-chairman/329156 In his past career Mr. Sommerville was Chairman for The Canadian Generic Pharmaceutical Association.
https://canadiangenerics.ca/news-release6/doug-sommerville-of-teva-canada-elected-chair-of-canadian-generic-pharmaceutical-association/ Chairman for The Canadian Generic Pharmaceutical Association, he probably has good relationship with all these companies. No wonder why QuestCap transitioned to a single-purpose medical company.
So, Doug Sommerville have lot of experience and once QuestCap get $100’s of million as revenue from covid-19 testing. QuestCap can expand its business in medical related services. So, at this point it does seem QuestCap have bright future for long term
QuestCap is also working on treatment for covid-19, even one of these 3 investment get any success can bring lot of revenue to QuestCap. - QuestCap invest $1 million in Sunnybrook and Sunnybrook is advancing research with the potential to stop the virus in its tracks. https://sunnybrook.ca/uploads/1/_foundation/why-give/covid19/stewardship-report-covid-19/your-impact_covid-19_july-2020.pdf
- QUESTCAP ANNOUNCES AGREEMENT TO ACQUIRE 40% OF SPECTRAL ANALYTICS: Spectral has completed in vitro studies performed at two independent pre-clinical clinical research organizations on a combination of two FDA approved drugs https://www.einpresswire.com/article/522569887/spectral-analytics-announces-positive-results-in-vitro-research-for-the-upcoming-patient-trial-for-covid-19-treatment
- Amino Therapeutics is currently focused on developing biologic therapeutics for COVID-19. Amnio’s research targets small molecule drug candidates and targeted drug delivery systems to transport biologics into the cytosol.